In this study, several modifications were introduced to a recently proposed human ventricular action potential (AP) model so as to render it suitable for the study of ventricular arrhythmias. These modifications were driven by new sets of experimental data available from the literature and the analysis of several well-established cellular arrhythmic risk biomarkers, namely AP duration at 90 per cent repolarization (APD 90 ), AP triangulation, calcium dynamics, restitution properties, APD 90 adaptation to abrupt heart rate changes, and rate dependence of intracellular sodium and calcium concentrations. The proposed methodology represents a novel framework for the development of cardiac cell models. Five stimulation protocols were applied to the original model and the ventricular AP model developed here to compute the described arrhythmic risk biomarkers. In addition, those models were tested in a one-dimensional fibre in which hyperkalaemia was simulated by increasing the extracellular potassium concentration, [K + ] o . The effective refractory period (ERP), conduction velocity (CV) and the occurrence of APD alternans were investigated. Results show that modifications improved model behaviour as verified by: (i) AP triangulation well within experimental limits (the difference between APD at 50 and 90 per cent repolarization being 78.1 ms); (ii) APD 90 rate adaptation dynamics characterized by fast and slow time constants within physiological ranges (10.1 and 105.9 s); and (iii) maximum S1S2 restitution slope in accordance with experimental data (S S1S2 = 1.0). In simulated tissues under hyperkalaemic conditions, APD 90 progressively shortened with the degree of hyperkalaemia, whereas ERP increased once a threshold in of AP models on the computation of arrhythmic risk biomarkers, as opposed to joining together independently derived ion channel descriptions to produce a whole-cell AP model, with the new framework providing a better picture of the model performance under a variety of stimulation conditions. On top of replicating experimental data at single-cell level, the model developed here was able to predict the occurrence of APD 90 alternans and areas of conduction block associated with high [K + ] o in tissue, which is of relevance for the investigation of the arrhythmogenic substrate in ischaemic hearts.
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Introduction
Mathematical modelling and simulation of the heart's electrical activity (so-called cardiac electrophysiology) and signal processing of bioelectrical signals provide an ideal framework to combine the information from clinical and experimental studies with the understanding of their underlying mechanisms. Tools capable of testing different hypotheses and predicting potential abnormalities in the heart's behaviour can be produced within that framework. In the relatively near future, it is not unlikely that those tools might even be used in clinical practice as complementary instruments to help in the prevention of cardiac diseases and the improvement of their diagnosis and therapy. Specifically, for the study of ventricular arrhythmias, it remains essential to have an action potential (AP) model able to reproduce experimentally and clinically observed arrhythmic behaviours at cell and tissue level. This would allow simulation of the electrical activity of the heart from the cell to the body surface and a total in silico reconstruction of the most well-known bioelectrical signal, the electrocardiogram, to be used for investigation of the mechanisms and manifestations of ventricular arrhythmias at different scales.
In the last few years, a number of mathematical models of electrical and ionic homeostasis in human ventricular myocytes have been proposed. One of the most extensively used models is the one proposed by ten Tusscher & Panfilov [1] (TP06), which is an improved version of the model described by ten Tusscher et al. [2] (TNNP04), where the calcium dynamics, the slow delayed rectifier potassium current (I Ks ) and the L-type calcium current (I CaL ) were reformulated. Both the TNNP04 and the TP06 models are based on experimental human data for most of the main ionic currents. One of the major advantages of the TP06 model against previous human ventricular models is that it accurately reproduces restitution of the AP duration (APD 90 ), as will be illustrated in §3 of this paper. On the other hand, the TP06 model has the major shortcomings of being insensitive to changes in certain ionic current densities [3] and of inadequately representing the rate dependence of intracellular calcium levels [4] , which will also be verified in the present study. Another relevant model of human ventricular cells was proposed by Iyer et al. [5] (IMW04). That model provides a detailed description of calcium homeostasis and reproduces diverse aspects of the excitation-contraction coupling (ECC). However, important limitations have been reported for this model, including the fact that it is extremely sensitive to variations in the sodium-potassium pump (I Na,K ) and inward rectifier potassium (I K1 ) current densities [3] and that it produces very long APs and relatively flat restitution curves in tissues [6] . On top of that, the most relevant ionic currents in the IMW04 model are described using Markovian chains, with the consequent increase in complexity (more than 60 state variables), which imposes serious restrictions on the size of the time step required for stability and increases the overall computational time when using this model in tissue simulations [6] . Recently, a new model of human ventricular AP has been proposed by Grandi et al. [7] (GPB). The development of that model departs from the rabbit ECC model proposed by Shannon et al. [8] , which includes the subsarcolemmal and junctional compartments in the formulation of the currents and provides a detailed description of calcium handling. The GPB model includes new definitions of ionic current densities and kinetics according to recent experimental data on human myocytes. This model is defined for two types of cells, namely endocardial and epicardial. The definitions of those two cell types differ only in the maximal conductivity of the fast and slow components of the transient outward potassium current (I to ). The GPB model improves the AP response to frequency changes and offers a better performance against blockades of potassium currents (I K1 , I Ks and the rapid delayed rectifier potassium current I Kr ) with respect to the TP06 model. The major drawback of the GPB model is that it does not adequately reproduce S1S2 restitution properties nor APD 90 rate adaptation dynamics, as will be illustrated in this study. Those drawbacks can be attributed to the fact that the GPB model was developed from a rabbit ventricular model, and the characteristics of S1S2 restitution and APD 90 rate adaptation are notably different in the two species. Table 1 presents a summary with the main differences between the three models described above, i.e. TP06, IMW04 and GPB.
Despite the fact that the human ventricular AP models currently available in the literature are able to reproduce certain electrophysiological properties, they fail in representing other relevant aspects, as pointed out above. In order to obtain a model suitable for the study of ventricular arrhythmias, in this study a human ventricular AP model was developed that departs from the GPB model. The methodology followed for model development was based on the computation of well-established arrhythmic risk biomarkers and the results of a sensitivity analysis of the modulation of those biomarkers by variations in the main ionic currents. Using that methodology, key limitations of the GPB model were unravelled and inadequacies in the definitions of specific ionic current characteristics were identified. Based on those findings, gating kinetics of the I CaL current were reformulated by introducing both fast and slow voltage-dependent inactivation gates [1] , maximal I Na,K was reduced to best match the experimental APD 90 rate adaptation data and the I K1 current was redefined by accounting for recent experimental data published in the literature [9] . The new model, developed by Carro et al. in this paper (CRLP), was tested and compared with the original GPB model and with the widely used TP06 model. The IMW04 model was left out of the comparison because of the limitations pointed out above. Model comparison was based on 12 cellular arrhythmic risk biomarkers computed using five different stimulation protocols, as in Romero et al. [4] . Our results show that the introduced modifications brought most biomarkers into the physiological range, and considerably improved others with respect to the GPB and the TP06 models. In addition, the CRLP Table 1 . Differences between human ventricular cell models. Data are obtained from Niederer et al. [3] , Romero et al. [4] and Bueno-Orovio et al. [6] and from simulations performed in this study. 
Methods

(a) Model development
In this study, a human ventricular cell model was developed that departs from the recently proposed GPB model. Before describing the modifications introduced into the new model, a brief description of the GPB model is in order.
(i) The GPB model
The GPB model describes the AP of endocardial and epicardial human myocytes. For both cell types, the total transmembrane ionic current, I ion , is given by
where each of the individual currents denotes the current generated on passing sodium, chlorine, calcium and potassium ions through the cell membrane, respectively. Sodium current. Following the approach of Shannon et al. [8] , the sodium current was divided into two components: (i) a subsarcolemmal component and (ii) a junctional component, which correspond to the cell compartments where the current is generated. Both components are formed by the same subcurrents:
I Na tot junc = I Na junc + I NaBk junc + 3I ncx junc + 3I Na,K junc + I Ca Na junc , I Na tot sl = I Na sl + I NaBk sl + 3I ncx sl + 3I Na,K sl + I Ca Na sl and I Na tot = I Na tot junc + I Na tot sl ,
where I Na is the fast sodium current, I NaBk is the background sodium current, I ncx is the current of the sodium-calcium exchanger, I Na,K is the current of the sodium-potassium pump and I Ca Na is the sodium current through the L-type calcium channels. Chlorine current. The chlorine current, which is not present in the TP06 model, is described in the GPB model by
where I ClCa is the calcium-activated chlorine current, and I ClBk is the background chlorine current.
Calcium current. The calcium current, as in the case of the sodium current, has two components, junctional and subsarcolemmal: where I Ca is the calcium current through the L-type calcium channels, I CaBk is the background calcium current, I pCa is the sarcolemmal calcium pump current and I ncx is the current of the sodium-calcium exchanger. Potassium current. The potassium current is defined as
where I to is the transient outward potassium current (decomposed into a fast and a slow component), I Kr is the rapidly activating potassium current, I Ks is the slowly activating potassium current (decomposed into junctional and subsarcolemmal components), I K1 is the inward rectifier potassium current, I Na,K is the current of the sodium-potassium pump (decomposed into junctional and subsarcolemmal components), I Ca K is the potassium current through the L-type calcium channels (decomposed into junctional and subsarcolemmal components) and I Kp is the plateau potassium current. In the GPB model, differentiation between endocardial and epicardial cells is set by assigning different contributions to the fast and slow I to components.
(ii) The CRLP model Taking the GPB model as a starting point, the CRLP model was built by reformulating two ionic currents (I CaL and I K1 ) and redefining a number of model parameters, including G Na (maximum I Na conductance) and G Na,K (maximal I Na,K value). Those changes were motivated by the poor performance exhibited by the GPB model on two particular aspects: (i) the shape and slope of the S1S2 APD 90 restitution curve, and (ii) the response of the APD 90 to abrupt changes in heart rate (see below). The failure of the GPB model in reproducing experimental data on those two aspects could be attributed to an inheritance from the Shannon rabbit ventricular model from which the GPB model was developed. In this regard, the development of the CRLP model from the GPB model was made by considering human data only [3] . The following paragraphs describe the introduced modifications, as well as the data and criteria used in the development process. A full description of the CRLP model along with a CellML implementation of it can be found in the electronic supplementary material.
In order to maintain as much consistency as possible with the original GPB model, the CRLP model was developed for the same type of myocardial cells as the GPB model, namely endocardial and epicardial. Differentiation between the two cell types was based on the definition of the I to fast and slow components, in the same way as previously described for the GPB model.
L-type calcium current (I CaL ). In order to obtain an APD 90 adaptation response to abrupt changes in cycle length (CL) in better concordance with experimental data, the L-type calcium current was reformulated. The voltage-dependent inactivation gate f of the GPB model was replaced with the product of a fast, f , and a slow, f 2 , inactivation gate, as in ten Tusscher et al. [1] . The new equations for the L-type current in the CRLP model are
I Ca Na = I Ca Na junc + I Ca Na sl and I CaL = I Ca + I Ca K + I Ca Na .
As indicated in Niederer et al. [3] , the replacement of one current component by another one is not a simple task. Splitting the f gate in the GPB model into two new gates required the readjustment of the time constants t f 2 associated with the slow voltage-dependent inactivation gate f 2 and the time constant t d associated with the activation gate d in order to obtain a meaningful I CaL current-voltage curve (splitting the f gate without readjusting the time constants would have led to a current-voltage curve having two relative minima). Readjustment of t f 2 was based on available experimental data [10] [11] [12] [13] [14] . Figure 1a depicts t f and t f 2 along with experimental data [10] [11] [12] [13] [14] . Since the experimental data do not cover the entire voltage range, the readjustment was performed by best fitting the tail of the t f 2 curve while obtaining a currentvoltage curve within the range of experimental data. The other voltage-dependent inactivation time constant, t f , was kept as in the study of ten Tusscher et al. [1] . The equations describing f and f 2 are:
where V m denotes transmembrane voltage. Readjustment of t d was based on the description provided in ten Tusscher et al. [1] :
The definitions of the calcium-dependent inactivation gates, f Ca B j and f Ca B sl , were taken as in the GPB model:
Additionally, based on the results of the sensitivity of APD 90 to variations in the maximal I CaL conductivity and the actual APD 90 value in the GPB model (see later tables), the relative permeabilities of the L-type calcium channels were set to:
e 2V m ×FoRT − 1 ,
e V m ×FoRT − 1 ,
where Frdy is Faraday's constant, FoRT is the ratio between Faraday's constant and the product of the gas constant and the absolute temperature,Ī k m is the maximal current for ion k in the compartment m, and p k is the relative permeability of ion k. The current-voltage curve obtained with the new definition of the I CaL current was compared with the experimental data [14] [15] [16] and with the original definition of the GPB model. Figure 1b shows the different current-voltage curves, where it can be observed that the new definition of I CaL is in good agreement with the available experimental data [14] [15] [16] , with the additional benefit of contributing to physiological model response in terms of S1S2 APD 90 restitution and APD 90 rate adaptation dynamics.
Inward rectifier K current (I K1 ). The I K1 current was redefined using recent experimental data from human ventricular cells published in the literature [9] . The new definition for I K1 is as follows:
where E K is the [K + ] reversal potential. Figure 1c shows the modified I K1 current compared with the experimental data from [9] and with I K1 from the GPB model. Na/K pump current (I Na,K ). In order to improve the APD 90 adaptation response to abrupt changes in CL, maximal I Na,K was reduced by 45 per cent with respect to its value in the GPB model. That reduction was set based on the results of the sensitivity analysis for the t slow biomarker that will be described below.
[ ] i makes the model more excitable when compared with the original GPB model because of the increased availability of sodium channels. Therefore, in order to obtain physiological values for the maximal upstroke velocity, dV /dt, in tissue, the maximum conductance of the sodium current, G Na , was reduced to 18.864 mS mF −1 . This modification led to a maximal upstroke velocity of 228 mV ms −1 in the simulated one-dimensional tissue (see below), which is in good agreement with the experimental results from [17] .
(iii) Numerical methods and implementation
The cell membrane was modelled as an electrical circuit [18] . Mathematically, the transmembrane voltage V m was described by the following ordinary differential equation:
where t is time, I ion is the sum of all transmembrane ionic currents, I stim is the externally applied stimulation current and C m is the cell capacitance per unit surface area. Propagation of the electrical activity in a one-dimensional fibre was described by the following parabolic reaction-diffusion equation [19] :
where s is the diffusion coefficient of the tissue and x denotes the coordinate along the fibre. Physical units in the model are as follows: time t is given in milliseconds, transmembrane potential V m in millivolts, current densities in picoamperes per picofarad, and ionic concentrations in millimoles per litre.
The GPB and CRLP models were implemented in Fortran based on the original codes provided by Eleonora Grandi. The TP06 model was also implemented in Fortran from the original C codes available at Kirsten ten Tusscher's web page: www-binf.bio.uu.nl/khwjtuss. A CellML implementation of the CRLP model is available in the electronic supplementary material.
Cells and tissues were stimulated with square transmembrane current pulses twice the diastolic threshold in amplitude and 1 ms duration. For single-cell simulations, forward Euler integration with a time step Dt = 0.002 ms was used to integrate the system of differential equations governing the cellular electrical behaviour. For the one-dimensional simulations, a homogeneous 4 cm long fibre composed of epicardial cells was considered. A semi-implicit operator-splitting scheme [20] was used to solve equation (2.2) with a space discretization of Dx = 0.1 mm and a time step of Dt = 0.002 ms. A value of s = 0.0013 cm 2 ms
was used, corresponding to a maximum CV of 74 cm s −1 , which is in agreement with experimentally reported CV values [21] . The cell capacitance was set to C m = 1 mF cm −2 . Five positions within the fibre were selected for further analysis in each simulation. Those positions were located at 1.5, 1.75, 2, 2.25 and 2.5 cm from the stimulation end of the cable. Reported APD 90 and CV values were computed as mean values over those positions. In all cases, the Rush and Larsen integration scheme [22] was used to integrate the Hodgkin-Huxley type equations for the gating variables of the various time-dependent currents (m, h and j for I Na ; x to f , x to s , y to f and y to s for I to ; x kr for I Kr ; x ks for I Ks ; and d, f and f 2 for I CaL ).
In order to test the sensitivity of the numerical solution to the time and space discretization indicated above, simulations were performed using a time increment of 0.5 ms and a spatial discretization of 0.05 mm. Differences of less than 0.2 per cent for the steady-state biomarkers computed in isolated cells were obtained when compared with the default time and space steps used in this study. In tissues, CV and APD 90 varied by less than 1.5 and 0.02 per cent, respectively. Also, other stimulus durations (from 1 to 3 ms) and amplitudes (from 1.5 to 2 times the diastolic threshold) were tested and confirmed to provide very similar results (differences in terms of APD 90 , maximal upstroke velocity as well as CV in tissues were in all cases below 0.2%, 1.6% and 0.8%, respectively).
(b) Arrhythmic risk biomarkers and stimulation protocols
Arrhythmic risk biomarkers were used in this study to guide the modifications applied to the GPB model to produce the CRLP model. Specifically, biomarkers related to S1S2 restitution and APD 90 rate adaptation dynamics were identified as not being adequately reproduced by the GPB model, and appropriate modifications (described in the previous section) were performed. Those and other biomarkers were also used to evaluate the performance of the CRLP model and compare it with that of the TP06 and GPB models.
In the following subsections, the cellular arrhythmic risk biomarkers used in this study are presented, and the protocols used to compute them are described.
(i) Selected biomarkers -APD 90 : APD has been traditionally considered as the main preclinical marker of drug cardiotoxicity. APD prolongation has been linked to long Q-T syndrome and increased risk of developing torsades de pointes [23, 24] . APD 90 is used in this study to denote AP duration at 90 per cent repolarization (figure 2a). -Triangulation: this biomarker quantifies the shape of the final part of the AP, and is calculated as the difference between APD at 50 and 90 per cent repolarization (figure 2a [25, 26] . In this study, diastolic (level at rest) and systolic (level at peak) calcium transient levels were evaluated at 0.5 and 1 Hz, respectively (figure 2b). -Time constants of APD 90 adaptation to abrupt changes in CL: adaptation of ventricular repolarization duration to abrupt changes in CL has been proposed as an arrhythmic risk marker [27] . In this study, the dynamics of APD 90 adaptation to abrupt changes in CL were fitted by two exponentials with associated time constants t fast and t slow (figure 2c), following the methodology proposed in Pueyo et al. [28] . -Maximum slope of APD 90 restitution curves: the maximum slope of the APD 90 restitution (APDR) curve has been suggested as an arrhythmic risk marker [29, 30] . The APDR curve describes the relationship between APD 90 and the diastolic interval (DI) (figure 2d-e). In this study, APDR was evaluated using the S1S2 and the dynamic protocols (see §2b(ii)).
- figure 2a,b ). -Abrupt changes in CL protocol: the cell was stimulated with a CL of 1000 ms for 8 min, then with a CL of 600 ms for an additional 8 min and finally with a CL of 1000 ms for 8 min (figure 2c). The APD 90 dynamics after the first abrupt CL change were fitted by two exponentials with time constants t fast and t slow . APD 90 adaptation dynamics after the second abrupt CL change provided very similar results to those obtained for the first CL change, in accordance with earlier studies [4, 28] , and are not reported. -S1S2 protocol: a train of 10 basic stimulations (S1) were applied to the cell or tissue at a CL of 1000 ms followed by an extra stimulus (S2) delivered at coupling intervals (CI) ranging from 1000 to 250 ms in variable steps (100 ms for DI > 300 ms, 5 ms for 150 < DI < 300 ms and 1 ms for 5 < DI < 150 ms). The S1S2 restitution curve was obtained by plotting the APD 90 corresponding to the extra stimulus versus the previous DI for each of the tested CI values (figure 2d). -Dynamic protocol: in this protocol, 100 stimulations were applied at a given CL, with the CL ranging from 1000 to 50 ms. The APDR curve was obtained by plotting the steady-state APD 90 (corresponding to the 100th stimulus of each CL) versus the corresponding steady-state DI (figure 2e ] i were measured at the end of the 10 min period. The maximum normalized concentration value was computed and used as a biomarker (figure 2f ).
(c) Conducted simulations (i) Sensitivity analysis
A sensitivity analysis was performed using the original GPB model following the methodology described in Romero et al. [4] . The aim was to elucidate how different ionic current properties modulate the investigated arrhythmic risk biomarkers. In the sensitivity analysis, each parameter was varied one at a time by ±30%. Also, variations of ±15% were considered to assess biomarkers' response to different degrees of variation. These percentages are in agreement with variability levels reported in experiments performed in human ventricular tissue [9, 14, [33] [34] [35] [36] [37] .
The following parameters were considered in the sensitivity analysis.
-G CaL : maximal conductance of the L-type calcium current (I CaL ).
-t f : time constant of the fast voltage-dependent inactivation gate (f ) of the I CaL current. -t f 2 : time constant of the slow voltage-dependent inactivation gate (f 2 ) of the I CaL current. -G Kr : maximal conductance of the rapidly activating potassium current (I Kr ). -G Ks : maximal conductance of the slowly activating potassium current (I Ks ). -t xs : time constant of the activation gate (x Ks ) of the I Ks current. -G K1 : maximal conductance of the inward rectifier potassium current (I K1 ).
-G Na,K : maximal value of the sodium-potassium pump current (I Na,K ). -G ncx : maximal value of the sodium-calcium exchanger current (I ncx ). -G to : maximal conductance of the transient outward potassium current (I to ).
For each biomarker c and parameter p, the percentage of change (D c,p,a ) and sensitivity (S c,p,a ) was calculated as follows [4] :
where C p,a is the value of biomarker c when the parameter p is varied by the percentage a, and C control is the value of biomarker c under control conditions. As shown above, sensitivity (S c,p,a ) was calculated as the ratio of the difference between the percentage of change (D c,p,a − D c,p,−a ) and the interval of change (2a). In this study, we used this definition particularized for a = 30%:
Larger percentages of variation (±60% and ±90%) in model parameters were additionally investigated to confirm the validity of the sensitivity analysis results under more severe ionic alterations.
(
ii) Potassium current blocks
The following cases of total and partial potassium current blocks were simulated.
-I Ks : to simulate the effect of 1 mM of HMR-1556, I Ks was completely blocked. -I Kr : to simulate the effect of 50 nM of dofetilide, I Kr was completely blocked. -I K1 : to simulate the effect of 10 mM of BaCl 2 , I K1 was reduced by 50 per cent. ] o value, the diastolic threshold used to compute the stimulus amplitude was determined as follows: The model was first stabilized until the product of the gates h × j reached 99 per cent of the steady-state value h ss × j ss . Stimulation current pulses of variable amplitude were applied at one end of the cable, and the diastolic threshold was defined as the minimum amplitude required for an AP to propagate along the fibre. With the model initialized at 1 Hz steady state, ERP was determined by stimulating the tissue with a train of 10 basic stimulations (S1) delivered at a CL of 1000 ms, followed by an extra stimulus (S2) delivered at different times taken in 1 ms steps. Steady-state CV and APD 90 were measured after the last S1 stimulus. Figure 3 presents APs computed from the TP06, GPB and CRLP models for an isolated epicardial cell and for an epicardial cell coupled in tissue. In all cases, APs correspond to steady-state pacing at CL = 1000 ms. As can be appreciated from the figure, the AP duration is of the same order in the three models. However, the AP shape is notably more triangular for the GPB and the CRLP models when compared with the TP06 model, which presents a flatter plateau phase. Also, phase 1 of the AP substantially differs from one model to another, particularly when comparing TP06 with the other two models. Those differences are to some extent attenuated when comparing APs measured in tissue. It is also clear from the figure that maximal upstroke velocity is considerably reduced for tissue APs when compared with cell APs. While for the GPB and CRLP models, maximum voltage occurs at the upstroke peak in both cell and tissue, for the TP06 model, the maximum voltage at the plateau is even larger than at the upstroke peak in tissue AP, as previously noted by Bueno-Orovio et al. [6] for the TNNP04 model from which the TP06 model was developed.
Results
(a) Results for control conditions (i) APs in cell and tissue
ii) Sensitivity analysis
The results of the sensitivity analysis applied to the epicardial version of the GPB model are presented in with the validation analysis presented in the following subsection were the road map to carry out the various model improvements proposed in this work, which were described in §2a.
To confirm that the results of the sensitivity analysis presented in table 2 were not dependent on the limit (30%) considered for parameter variations, simulations were performed considering larger percentages of variations of up to 90 per cent. Despite the fact that, in some cases, a highly nonlinear modulation of specific risk biomarkers by certain ionic mechanisms was observed (e.g. triangulation modulation by G K1 , systolic [Ca 2+ ] i modulation by G CaL or t slow modulation by G Na,K ), the results corroborated the mechanisms identified as determinant for the investigated risk biomarkers in the sensitivity analysis.
(iii) Arrhythmic risk biomarkers Table 3 shows the values of the computed biomarkers for the epicardial versions of the three models analysed in this study (TP06, GPB and CRLP). Simulation results were compared against a variety of experimental data taken from earlier studies [14, 17, 25, [38] [39] [40] [41] [42] [43] .
Results indicate that the GPB model performs better than the TP06 model with respect to the following biomarkers: AP triangulation, steady-state systolic and diastolic [Ca 2+ ] i levels at 0.5 Hz, and rate dependence of [Na + ] i and [Ca 2+ ] i . Those biomarkers are illustrated for the three analysed models in figure 4a-g. However, according to other analysed biomarkers, the GPB model renders worse performance than the TP06 model, as is the case for the S1S2 restitution curve and the APD 90 adaptation to abrupt changes in CL. Regarding the APD 90 adaptation, two phases of APD 90 rate adaptation were experimentally reported in the study of Franz et al. [38] : a first phase with a short time constant and a second phase with a longer time constant. As described in §3a(ii), the APD 90 rate response in the GPB model does not present the first fast phase (figure 4c). For the S1S2 restitution curves (figure 4d), the TP06 model is in better agreement with the experimental data of earlier studies [38, 42] than the GPB model. For the CRLP model, seven out of 12 analysed biomarkers are within physiological range and the other three are closer to the physiological range when compared with the GPB and the TP06 models. As for systolic and diastolic [Ca 2+ ] i levels at 1 Hz, TP06 outperforms CRLP. A significant change in the shape of the S1S2 restitution curve is observed for the CRLP model when compared with the GPB model (figure 4d). The behaviour shown by the CRLP model is in agreement with the experimental data [38] .
(iv) Potassium current blocks Table 4 summarizes the effect of potassium current blocks on epicardial APs computed using the three tested models. Results are given as percentage of variation of the APD 90 value with respect to control conditions. In those cases where more than one current was blocked, the variation refers to the APD 90 value obtained when only the first current was blocked. Experimental values are taken from the study of Jost et al. [44] . It is clear from table 4 that the GPB model performs better than the TP06 model regarding current blocks. The CRLP model performs similar to the GPB model. Figure 5 illustrates the effect of current blocks on the AP shape for the GPB and CRLP models. [47] [48] [49] . We tested the same hyperkalaemic conditions in simulated TP06 and GPB one-dimensional fibres and we could not observe branching out of the ERP or APD 90 curves after increasing [K + ] o up to 15 mM. Figure 8c depicts AP propagation in the simulated CRLP one-dimensional fibre for [K + ] o = 10 mM. Alternans were observed for all computed positions within the fibre. Figure 8d shows I CaL , I Na and [Ca 2+ ] i , each normalized to its maximum value, for the same time period shown in figure 8c. Results indicate that conduction relies on I Na even for the highly depressed APs. For the long APs, the AP upstroke is divided into two components, the first one characterized by a steep upstroke and supported by I Na , and the second one supported by I CaL , in agreement with the results reported in [50] . 
Discussion and conclusions
In this study, a new human ventricular cell model, the CRLP model, was developed based on the recently proposed GPB model. The CRLP model combines recent experimental measurements of potassium currents, and reformulates the L-type calcium current by introducing fast and slow voltage-dependent inactivation gates, similar to the formulation proposed in the TP06 model. That new formulation led to I CaL dynamics that were in good agreement with experimental data and, more notably, allowed the CRLP model to accurately reproduce S1S2 restitution and APD 90 rate adaptation characteristics. All the modifications were made with the aim of maintaining the advantages that the GPB model has over previous models, such as the TP06 model, while improving the performance on other electrophysiological aspects. The novelty of this study was that model development was not only based on the incorporation of new data from experiments on individual ionic currents or concentrations. More importantly, the development was driven by analysing the ability of the model to replicate a set of well-established arrhythmic risk biomarkers, and on a sensitivity analysis of those biomarkers to variations in model parameters. The proposed model development framework allows model performance to be assessed under a variety of conditions, either physiological or pathological. This provides useful information for the adjustment of different model parameters that do not directly depend on individual current measurements or concentrations, and which would otherwise be set in an ad hoc manner.
(a) Modifications
The introduction of fast and slow I CaL inactivation gates in the CRLP model led to a more physiological APD 90 rate adaptation response to abrupt changes in CL when compared with the GPB model. However, by doing so, a larger I CaL current was obtained for the CRLP model, which led to the reformulation of I K1 and readjustments of other parameters in order to keep APD 90 within physiological values. The resulting APD 90 value for the CRLP model was closer to the APD 90 value of the TP06 model, without significantly altering the AP triangulation of the GPB model, which was well within the reported physiological range. The other modifications introduced into the CRLP model rendered most of the investigated biomarkers to be within the physiological range or otherwise closer to the physiological range when compared with the GPB and the TP06 models. In this regard, it was only for systolic and diastolic [Ca 2+ ] i levels at 1 Hz that TP06 outperformed CRLP. In addition, the CRLP model showed improved performance with respect to the GPB model regarding the S1S2 restitution, not only by bringing the maximum S1S2 restitution slope within the physiological range, but also by providing a shape for the restitution curve in good agreement with the experimental measurements [38] .
Even though the modifications significantly improved the performance of the CRLP model over the GPB model in reproducing experimental data related to a number of arrhythmic risk biomarkers, they have minimally affected the behaviour of the model against potassium current blocks. In this regard, the CRLP model still provides results in very good agreement with the available experimental data regarding AP response to I Kr , I Ks and I K1 blocks [44] . These results are in agreement with experimental studies, where alternans were observed in the cells of the heart's ischaemic zone [47, 48] . To the authors' knowledge, this is the first time that those observations have been reported using a human ventricular AP model. That type of behaviour was not observed in either the TP06 or the GPB models. For the TP06 model, conduction block occurred for [K + ] o ≈ 15 mM without the occurrence of alternans [51] . For the GPB model, conduction block occurred for [K + ] o ≈ 9 mM and alternans were not observed either.
(c) Data sources
As described in the study of Niederer et al. [3] , one of the problems on reutilization of model components in electrophysiology is the inclusion of components adjusted with data from different species. For that reason, in this work all the modifications were made by using model components formulated based on human data only [1] or by fitting equations to additional human data available from the literature [9] . We did not try modifying other ionic currents or concentrations for which human data were not available. Regarding the types of human data used in the study, they all corresponded to adult humans, except for the data taken from the study by Pelzmann et al. [15] , in which I CaL was measured in children. Those data were used because the study clearly showed that there were not significant differences in the I CaL current characteristics measured in children when compared with adults.
(d) Model limitations
The developed CRLP model has a number of limitations, some of them inherited from the GPB model on which it was based, and others independent of it. Phase 1 of the AP shows an atypical behaviour. We believe this behaviour is caused by the I to current. However, we have not attempted to modify this current mainly because new human data were not available for that purpose. This current happens to be the only one whose definition differentiates endocardial and epicardial cells in the GPB model and in the CRLP model as well. A second limitation of the CRLP model, which is also a limitation of the GPB model, is that a description is not provided for the electrophysiology of mid-myocardial cells. Another limitation of the CRLP model has to do with calcium definition. The results of the analysis conducted in this study point out the importance that the I CaL current as well as the [Ca 2+ ] i dynamics have over different arrhythmic risk biomarkers. Many studies have attempted to provide accurate definitions of [Ca 2+ ] i dynamics in human ventricular cells, but this is still an area of intensive research. The present study suggests the need to continue with the development of more reliable calcium dynamics models that allow the performance of whole-cell AP models to be improved.
On top of the above-described limitations, a comment is in order regarding the comparison of human ventricular AP models. It is clear that each model has been developed to reproduce certain electrophysiological behaviours observed from experimental recordings. Also, considering the huge variability in the experimental data, model comparison becomes a challenging task for which a model should never be qualified as being an improvement over another one just because it is able to reproduce specific experimental observations that the other model is not able to. In this study, we used the term 'improvement' exclusively to refer to the fact that, considering the set of investigated arrhythmic risk biomarkers, the CRLP model provides a response that is more in line with the averaged experimental data used for evaluation purposes.
(e) Future work
Although the results of this study showed the value of the proposed framework for the development of ionic models, further research is needed to investigate how arrhythmic risk biomarkers are modulated by the interaction of different model parameters when those parameters vary simultaneously. In this regard, an analysis of variance of the studied biomarkers can provide additional useful information for adjusting independent parameters in order to bring a given biomarker into the physiological range without greatly affecting other biomarkers in the process. Future developments of the model will continue in this direction, as well as in adapting the model for simulating ischaemia through the incorporation of ATP-sensitive potassium channels (I KATP ). Simulations with the CRLP model will be conducted not only in a one-dimensional fibre, but in two-dimensional tissue and in a realistic human ventricular geometry.
